Generics and Biosimilars in Central and Eastern Europe 2013 is a conference that covers topics such as:
- Legal and regulatory framework
- Overview of the generics and biosimilars landscape in CEE
- How to access the market in CEE
- Various partnering strategies
- Differentiation strategies for generics, focusing on super generics
Generics and Biosimilars in Central and Eastern Europe 2013 brings together:
- Pharmaceutical and biotech companies
- CEE, European and Global generics and biosimilars manufacturers
- Leading industry experts
- Regulators
- Key decision makers
